Morten Ruhwald

Morten Ruhwald, MD, PhD leads the TB programme at FIND in Geneva, Switzerland. Prior to joining FIND Morten was Chief Medical Officer at Statens Serum Institut in Copenhagen, Denmark where he oversaw the clinical development of the TB and Chlamydia vaccine programs and clinical development of the specific skin test Cy-Tb/C-Tb for TB infection. At FIND Morten is responsible for a large portfolio of development projects and clinical trials spanning biomarkers, next generation LAM assays, molecular assays for TB and drug resistance detection, digital diagnostics and AI based tools. A key aim of the program is to develop and trial new non-sputum based tests and sampling strategies to enable the post pandemic recovery of TB programs in LMICs.